Short hairpin RNA-mediated knockdown of VEGFA in müller cells reduces intravitreal neovascularization in a rat model of retinopathy of prematurity

American Journal of Pathology

Volumn 183, Issue 3, 2013, Pages 964-974

  Wang, Haibo ^a   Smith, George W ^a   Yang, Zhihong ^a   Jiang, Yanchao ^a   McCloskey, Manabu ^a   Greenberg, Kenneth ^b   Geisen, Pete ^c   Culp, William D ^c   Flannery, John ^d   Kafri, Tal ^c   Hammond, Scott ^c   Hartnett, M Elizabeth ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Spiral Devices LLC   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; LENTIVIRUS VECTOR; MESSENGER RNA; NEUTRALIZING ANTIBODY; SHORT HAIRPIN RNA; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MUELLER CELL; NEOVASCULARIZATION (PATHOLOGY); NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA BLOOD VESSEL; RETROLENTAL FIBROPLASIA; UPREGULATION; WEIGHT GAIN;

ALTERNATIVE SPLICING; ANIMALS; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; EPENDYMOGLIAL CELLS; GENE KNOCKDOWN TECHNIQUES; GENETIC VECTORS; HUMANS; LENTIVIRUS; PROTEIN TRANSPORT; RATS; RETINAL NEOVASCULARIZATION; RETINOPATHY OF PREMATURITY; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STAINING AND LABELING; TRANSDUCTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84883179295     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.05.011     Document Type: Article

References (48)

1. N. Ashton Editorial: retrolental fibroplasia now retinopathy of prematurity Br J Ophthalmol 68 1984 689
2. A. Patz Current therapy of retrolental fibroplasia: retinopathy of prematurity Ophthalmology 90 1983 425 427
3. I.C. Michaelson The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases Trans Ophthalmol Soc U K 68 1948 137 180
4. P. Shah, V. Narendran, N. Kalpana, and C. Gilbert Severe retinopathy of prematurity in big babies in India: history repeating itself? Indian J Pediatr 76 2009 801 804
5. A. Hellstrom, C. Peruzzu, M. Ju, E. Engstrom, A.-L. Hard, J.-L. Liu, K. Albertsson-Wickland, A. Niklasson, L. Sjodell, D. LeRoith, D. Senger, and L.E.H. Smith Low IGF-1 suppresses VEGF-survival signalling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity Proc Natl Acad Sci U S A 98 2001 5804 5808
6. T. Kondo, D. Vicent, K. Suzuma, M. Yanagisawa, G.L. King, M. Holzenberger, and C.R. Kahn Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization J Clin Invest 111 2003 1835
7. S. Ding, T. Merkulova-Rainon, Z.C. Han, and G. Tobelem HGF receptor up-regulation contributes to the angiogenic phenotype of human endothelial cells and promotes angiogenesis in vitro Blood 101 2003 4816
8. J. Chen, K.M. Connor, C.M. Aderman, and L.E. Smith Erythropoietin deficiency decreases vascular stability in mice J Clin Invest 118 2008 526 533
9. J. Chen, K.M. Connor, C.M. Aderman, K.L. Willett, O.P. Aspegren, and L.E.H. Smith Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy Invest Ophthalmol Vis Sci 50 2009 1329 1335
10. H. Wang, G. Byfield, Y. Jiang, G.W. Smith, M. McCloskey, and M.E. Hartnett VEGF-mediated STAT3 activation inhibits retinal vascularization by down-regulating local erythropoietin expression Am J Pathol 180 2012 1243 1253
11. J.L. Wilkinson-Berka, S. Babic, T. de Gooyer, A.W. Stitt, K. Jaworski, L.G.T. Ong, D.J. Kelly, and R.E. Gilbert Inhibition of platelet-derived growth factor promotes pericyte loss and angiogenesis in ischemic retinopathy Am J Pathol 164 2004 1263 1273
12. K. Abdulmalek, F. Ashur, N. Ezer, F. Ye, S. Magder, and S.N. Hussain Differential expression of Tie-2 receptors and angiopoietins in response to in vivo hypoxia in rats Am J Physiol Lung Cell Mol Physiol 281 2001 L582 L590
13. S. Sarlos, B. Rizkalla, C.J. Moravski, Z. Cao, M.E. Cooper, and J.L. Wilkinson-Berka Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin Am J Pathol 163 2003 879 887
14. T.L. Young, D.C. Anthony, E. Pierce, E. Foley, and L.E. Smith Histopathology and vascular endothelial growth factor in untreated and diode laser-treated retinopathy of prematurity J AAPOS 1 1997 105 110
15. K. Sonmez, K.A. Drenser, A. Capone Jr., and M.T. Trese Vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity Ophthalmology 115 2008 1065 1070
16. A.P. Adamis, J.W. Miller, M.T. Bernal, D.J. D'Amico, J. Folkman, T.K. Yeo, and K.T. Yeo Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy Am J Ophthalmol 118 1994 445 450
17. A.C. Clermont, L.P. Aiello, F. Mori, L.M. Aiello, and S.E. Bursell Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy Am J Ophthalmol 124 1997 433 446
18. I.A. Bhutto, D.S. McLeod, T. Hasegawa, S.Y. Kim, C. Merges, P. Tong, and G.A. Lutty Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration Exp Eye Res 82 2006 99 110
19. A.J. Churchill, J.G. Carter, H.C. Lovell, C. Ramsden, S.J. Turner, A. Yeung, J. Escardo, and D. Atan VEGF polymorphisms are associated with neovascular age-related macular degeneration Hum Mol Genet 15 2006 2955 2961
20. P.J. Rosenfeld, D.M. Brown, J.S. Heier, D.S. Boyer, P.K. Kaiser, C.Y. Chung, R.Y. Kim MARINA Study Group Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 2006 1419 1431
21. T. Chan-Ling, P. Halasz, and J. Stone Development of retinal vasculature in the cat: processes and mechanisms Curr Eye Res 9 1990 459 478
22. Y. Zhang, R.M. Porat, T. Alon, E. Keshet, and J. Stone Tissue oxygen levels control astrocyte movement and differentiation in developing retina Brain Res Dev Brain Res 118 1999 135 145
23. T. Baba, D.S. McLeod, M.M. Edwards, C. Merges, T. Sen, D. Sinha, and G.A. Lutty VEGF 165b in the developing vasculatures of the fetal human eye Dev Dyn 241 2012 595 607
24. Y. Liu, A.D. Berendsen, S. Jia, S. Lotinun, R. Baron, N. Ferrara, and B.R. Olsen Intracellular VEGF regulates the balance between osteoblast and adipocyte differentiation J Clin Invest 122 2012 3101 3113
25. M. Saint-Geniez, A.E. Maldonado, and P.A. D'Amore VEGF expression and receptor activation in the choroid during development and in the adult Invest Ophthalmol Vis Sci 47 2006 3135 3142
26. J. Hu, M.P. Blair, M.J. Shapiro, S.J. Lichtenstein, J.M. Galasso, and R. Kapur Reactivation of retinopathy of prematurity after bevacizumab injection Arch Ophthalmol 130 2012 1000 1006
27. M. McCloskey, H. Wang, Y. Jiang, G.W. Smith, J. Strange, and M.E. Hartnett Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurity Invest Ophthalmol Vis Sci 54 2013 2020 2026
28. J.M. Holmes, and L.A. Duffner The effect of postnatal growth retardation on abnormal neovascularization in the oxygen exposed neonatal rat Curr Eye Res 15 1996 403 409
29. S. Cunningham, B.W. Fleck, R.A. Elton, and N. Mclntosh Transcutaneous oxygen levels in retinopathy of prematurity Lancet 346 1995 1464 1465
30. S.J. Budd, H. Thompson, and M.E. Hartnett Association of retinal vascular endothelial growth factor with avascular retina in a rat model of retinopathy of prematurity Arch Ophthalmol 128 2010 1014 1021
31. T.M. Sandercoe, S.F. Geller, A.E. Hendrickson, J. Stone, and J.M. Provis VEGF expression by ganglion cells in central retina before formation of the foveal depression in monkey retina: evidence of developmental hypoxia J Comp Neurol 462 2003 42 54
32. M.A. Behzadian, X.L. Wang, M. Shabrawey, and R.B. Caldwell Effects of hypoxia on glial cell expression of angiogenesis-regulating factors VEGF and TGF-beta Glia 24 1998 216 225
33. M. Saint-Geniez, T. Kurihara, E. Sekiyama, A.E. Maldonado, and P.A. D'Amore An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris Proc Natl Acad Sci U S A 106 2009 18751 18756
34. Y. Bai, J.X. Ma, J. Guo, J. Wang, M. Zhu, Y. Chen, and Y.Z. Le Müller cell-derived VEGF is a significant contributor to retinal neovascularization J Pathol 219 2009 446 454
35. E.A. Pierce, R.L. Avery, E.D. Foley, L.P. Aiello, and L.E.H. Smith Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization Proc Natl Acad Sci U S A 92 1995 905 909
36. A. Weidemann, T.U. Krohne, E. Aguilar, T. Kurihara, N. Takeda, M.I. Dorrell, M.C. Simon, V.H. Haase, M. Friedlander, and R.S. Johnson Astrocyte hypoxic response is essential for pathological but not developmental angiogenesis of the retina Glia 58 2010 1177 1185
37. M.E. Hartnett, and J.S. Penn Mechanisms and management of retinopathy of prematurity N Engl J Med 367 2012 2515 2526
38. J.S. Penn, M.M. Henry, and B.L. Tolman Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat Pediatr Res 36 1994 724 731
39. M.E. Kleinman, K. Yamada, A. Takeda, V. Chandrasekaran, M. Nozaki, J.Z. Baffi, R.J.C. Albuquerque, S. Yamasaki, M. Itaya, Y. Pan, B. Appukuttan, D. Gibbs, Z. Yang, K. Kariko, B.K. Ambati, T. Wilgus, L.A. DiPietro, E. Sakurai, K. Zhang, J.R. Smith, E.W. Taylor, and J. Ambati Sequence- and target-independent angiogenesis suppression by siRNA via TLR3 Nature 452 2008 591 597
40. K.P. Greenberg, S.F. Geller, D.V. Schaffer, and J.G. Flannery Targeted transgene expression in Muller glia of normal and diseased retinas using lentiviral vectors Invest Ophthalmol Vis Sci 48 2007 1844 1852
41. P. Geisen, L.J. Peterson, D. Martiniuk, A. Uppal, Y. Saito, and M.E. Hartnett Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity Mol Vis 14 2008 345 357
42. K. Allegaert, C. Vanhole, I. Casteels, G. Naulaers, A. Debeer, V. Cossey, and H. Devlieger Perinatal growth characteristics and associated risk of developing threshold retinopathy of prematurity J AAPOS 7 2003 34 37
43. M.E. Hartnett Studies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an American Ophthalmological Society thesis) Trans Am Ophthalmol Soc 108 2010 96 119
44. J.R. McColm, P. Geisen, and M.E. Hartnett VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP Mol Vis 10 2004 512 520
45. F. Stegmeier, G. Hu, R.J. Rickles, G.J. Hannon, and S.J. Elledge A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells Proc Natl Acad Sci U S A 102 2005 13212 13217
46. J.C. Giering, D. Grimm, T.A. Storm, and M.A. Kay Expression of shRNA from a tissue-specific pol II promoter is an effective and safe RNAi therapeutic Mol Ther 16 2008 1630 1636
47. L. Tian, P. Yang, B. Lei, J. Shao, C. Wang, Q. Xiang, L. Wei, Z. Peng, and A. Kijlstra AAV2-mediated subretinal gene transfer of hIFN-alpha attenuates experimental autoimmune uveoretinitis in mice PLoS One 6 2011 e19542
48. W. Shen, M. Fruttiger, L. Zhu, S.H. Chung, N.L. Barnett, J.K. Kirk, S. Lee, N.J. Coorey, M. Killingsworth, L.S. Sherman, and M.C. Gillies Conditional Müller cell ablation causes independent neuronal and vascular pathologies in a novel transgenic model J Neurosci 32 2012 15715 15727